INDV:NASDAQ
Indivior Pharmaceuticals Inc
$34.88
arrow_downward
-2.27%(-0.81) 1D
$34.78
arrow_downward
-0.29% (-0.10)bedtimeAfter hours
Closed: Sep 18, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INDV...
Open
$35.59
High
$35.62
Low
$34.59
Mkt. cap
4.12B
Avg. vol.
2.03M
Volume
4.68M
P/E ratio
12.56
52-wk high
$42.81
52-wk low
$22.30
EPS
$2.78
Beta
1.03
Shares outstanding
118.03M
No. of employees
833
Open
$35.59
High
$35.62
Low
$34.59
Mkt. cap
4.12B
Avg. vol.
2.03M
Volume
4.68M
P/E ratio
12.56
52-wk high
$42.81
52-wk low
$22.30
EPS
$2.78
Beta
1.03
Shares outstanding
118.03M
No. of employees
833
News stories
From web sources and news partners
AD HOC NEWS
·
2 hours ago
Indivior stock holds steady as investors watch fundamentals and momentum
CarePlus VietNam
·
4 weeks ago
Indivior (INDV) Results Review: Profit Per Share Surpasses Its Benchmark in the Current Update
CarePlus VietNam
·
4 weeks ago
Indivior (INDV) Range: Slides 2.41% to $36.87 at the Close; Technical Setup: Support at $35.03 and Resistance at $38.71 Frame the Range in the Latest Session - GEX Level
CarePlus VietNam
·
2 months ago
INDV Q1 2026 Earnings: EPS Surges Past Estimates by Over 43% as Stock Declines - Analyst Drop Coverage
Profile
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. Wikipedia
About Indivior Pharmaceuticals Inc
CEOMark Crossley
Employees833
FoundedSep 26, 2014
Headquarters-
SectorPharmaceutical industry
Websiteindivior.com